Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,009.50    -16.50 (-1.61%)
Bid:
1,014.50
Ask:
1,015.50
Spread: 1.00 (0.099%)
Market Cap: £4.97b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Final Terms

10 Jul 2026 17:35

RNS Number : 9659L
Babcock International Group PLC
10 July 2026
 

 

 

10 July 2026

Babcock International Group PLC

 

BABCOCK INTERNATIONAL GROUP PLC £250 million BOND ISSUE

Babcock International Group ('the Group' or 'Babcock') announces the issue of £250 million of five-year bonds carrying fixed coupon of 5.125%, the Group's first bond issue for seven years, to refinance the £300 million bond maturing in October 2026.

 

Babcock's strong proposition, fundamentals and balance sheet, combined with leading market positioning in defence and nuclear, has led to a high level of demand, allowing us to price on attractive terms.

 

The net proceeds of the issue will be used for general corporate purposes, including ongoing investment to support and drive growth.

 

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 10 July 2026 (the "Final Terms") relating to the issue by Babcock on 14 July 2026 of GBP 250,000,000 5.125% per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 3 March 2026 (the "Base Prospectus") relating to the £3,000,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9659L_1-2026-7-10.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

 

Andrew Gollan

Samuel MacGregor

Director of Investor Relations

Investor Relations Manager

Tel: (0)7936 039004

Tel: (0)7730 753159

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTRMMFTMTJBBBF
Date   Source Headline
21st Oct 20217:00 amRNSSale of Frazer-Nash and half year trading update
24th Sep 20213:16 pmRNSDirector/PDMR Shareholding
24th Sep 20211:49 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSAnnual General Meeting
13th Sep 20217:00 amRNSSale of stake in AirTanker Holdings
1st Sep 20217:00 amRNSSale of Oil and Gas aviation business
25th Aug 202110:50 amRNSDirector/PDMR Shareholding
18th Aug 20214:44 pmRNSNotice of Availability
13th Aug 20217:00 amRNSSale of Frazer-Nash Consultancy
30th Jul 20213:08 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSFull year results for the year ended 31 March 2021
13th Apr 20217:00 amRNSBusiness update
7th Apr 20219:41 amRNSHolding(s) in Company
26th Feb 202110:44 amRNSHolding(s) in Company
26th Jan 20219:48 amRNSHolding(s) in Company
25th Jan 20213:19 pmRNSHolding(s) in Company
20th Jan 20212:50 pmRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSTrading update
8th Jan 20213:23 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBabcock appoints new Marine CEO
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.